- Home
- NWBI vs NKTR Comparison
NWBI vs NKTR Comparison
Compare NWBI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWBI | NKTR |
|---|---|---|
| Founded | 1896 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2009 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NWBI | NKTR |
|---|---|---|
| Price | $15.33 | $71.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $14.50 | ★ $146.67 |
| AVG Volume (30 Days) | ★ 795.6K | 524.9K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.82% | N/A |
| EPS Growth | ★ 16.46 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $307,711,000.00 |
| Revenue This Year | $6.29 | N/A |
| Revenue Next Year | $5.06 | N/A |
| P/E Ratio | $21.59 | ★ N/A |
| Revenue Growth | N/A | ★ 86.00 |
| 52 Week Low | $11.25 | $27.87 |
| 52 Week High | $16.16 | $109.00 |
Technical Indicators
Market Signals| Indicator | NWBI | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 47.52 |
| Support Level | $15.07 | $70.48 |
| Resistance Level | $15.47 | $76.45 |
| Average True Range (ATR) | 0.19 | 2.81 |
| MACD | -0.06 | -0.39 |
| Stochastic Oscillator | 31.45 | 23.74 |
Price Performance
Historical ComparisonAbout NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.